J&J has launched its Shockwave C2 Aero Coronary IVL Catheter globally, marking an advancement in the treatment of calcified ...

Slowing progression remission quiet marks a shift in nephrology with Monogram Health’s holistic, algorithm-driven in-home ...

Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test ResultsLicensing Agreement ...

Key Points Interested in Compugen Ltd.? Here are five stocks we like better. COM701 ovarian trial is on schedule: Compugen said all sites are open and enrolling in its MAIA-ovarian study, and ...

However, there is another field where artificial intelligence is producing an even more profound transformation: medicine and ...

Johnson & Johnson (NYSE: JNJ) announced today the global launch of its Shockwave C2 Aero Coronary IVL Catheter designed for ...

FDA accepted sNDA for IGALMI® use in at-home (outpatient) setting; set Nov. 14, 2026, as PDUFA date Advancing BXCL501 as a potential acute ...

The content of this call contains time-sensitive information that is accurate only as of today, Wednesday, May 13, 2026. Except as required by law, Journey Medical disclaims any obligation to publicly ...

TIME and Statista name the 500 most impactful companies in the world in terms of economic significance and net positive ...

You are not the first generation in America to confront this question: whether the unjust concentration of power is permanent ...

Both Rising-Star Researchers and Senior Clinicians, and Advocates from around the World Present New Study Findings in ...

Ramsey Alloush disclosed that, while broad coverage is achieved, only about 34% of the commercial covered lives currently access AAMROCI with preferred prior authorization and step edit terms—"about ...